Form4insider filings, from the source

SEC Form 4 · accession 0001181431-15-008374

SUPERNUS PHARMACEUTICALS, INC. · SUPN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
M James Barrett
Director · 10% Owner
Period of report
Jun 15, 2015
Accepted (ET)
Jun 17, 2015 · 8:35 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jun 15, 2015J3,000,000$0.00D7,641,250ISee Note 2
Common StockF4Jun 15, 2015J921,000$0.00A921,000ISee Note 4
Common StockF4Jun 15, 2015J921,000$0.00D921,000ISee Note 4
Common StockJun 15, 2015J32,524$0.00A32,524D
Common StockF8Jun 15, 2015J16,262$0.00A16,262ISee Note 8
Common StockF10Jun 15, 2015J9,406$0.00A9,406ISee Note 10
Common StockF12Jun 15, 2015J6,856$0.00A6,856ISee Note 12
Common StockF14Jun 15, 2015J166,986$0.00A166,986ISee Note 14
Common StockF15,F14Jun 16, 2015S55,105$16.8527D111,881ISee Note 14

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses